EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 FoundationRead more →

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Bill's Patient Story

Patient Info: Bill, Male | Stage IV

Biomarkers: EGFR exon 21 mutation

Metastatic Site: Spine; brain; hips/bone

Stage IV EGFR exon 21 lung cancer improved in brain and spine on osimertinib, but later lung-mass growth led to clinical-trial treatment; Bill remained active in advocacy and felt positive about progress.

Lung Cancer Research FoundationRead more →

Stage IV ALK Non-Small Cell Lung Cancer: Suzanne's Patient Story

Patient Info: Suzanne, Female | Stage IV

Biomarkers: ALK mutation identified on tissue biopsy; blood biomarker test was negative

Metastatic Site: Not specified

Stage IV ALK-positive lung cancer was stable for almost 4 years on alectinib before progression in mid-2023; Suzanne moved to brigatinib and radiation and was working toward stability again.

Lung Cancer Research FoundationRead more →

Stage IV Non-Small Cell Lung Cancer: Amy's Patient Story

Patient Info: Amy, Female | Stage IV

Metastatic Site: Neck lymph node; bones — hips, femurs, foot; adrenal…

Living 5 years after Stage IV squamous NSCLC diagnosis, after Keytruda did not work and treatment included bone radiation, SBRT to the lung nodule, and adrenal cryoablation.

Lung Cancer Research FoundationRead more →

Stage III ROS1 Non-Small Cell Lung Cancer: Wendy's Survivor Story

Patient Info: Wendy, Female | Stage III

Biomarkers: ROS1-positive / ROS1-rearranged

Completed chemoradiation, surgery, and post-surgery radiation for Stage III ROS1-positive NSCLC by January 2017 and later shared a long-term survivor/advocacy story; no explicit NED statement is given.

Lung Cancer Research FoundationRead more →

Stage III Colorectal Cancer: Nick's Survivor Story

Patient Info: Nick Cleworth, Male, 40s | Stage III

Cancer-free after ARTEMIS clinical-trial treatment for node-positive rectal cancer, avoiding surgery and a permanent colostomy.

The Christie NHSRead more →

Stage IV Colorectal Cancer: Hong's Patient Story

Patient Info: Hong Wentong, Male | Stage IV

Metastatic Site: Liver

Responded well to interventional therapy plus radioactive seed implantation for Stage IV sigmoid colon cancer with liver metastasis, with liver tumor shrinkage, better disease control, and 3 kg weight gain.

Colorectal Cancer: Hatta's Survivor Story

Patient Info: Hatta, Male

No recurrence reported after interventional therapy, biological immunotherapy, Chinese medicine, and local radiotherapy for rectal cancer; later CT report was described as showing no cancer cells, with 8 years of normal life and annual checks.

How Learning To Ask For Help Can Make Life With MBC Easier

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: Not explicitly reported; HER2-targeted treatment with Herceptin and Tykerb reported

Metastatic Site: Brain; liver

Living with Stage IV metastatic breast cancer involving brain and liver; latest scans showed no evidence of disease, and she reported spending most of her Stage IV life in NED status.

breastcancer.orgRead more →

Breast Cancer: Genevieve's Survivor Story

Patient Info: Genevieve, Female, 40s

Biomarkers: 1987 tumor not hormone-receptive; 2017 tumor hormone-receptive. 2022 full marker panel not stated.

After breast cancer episodes beginning in 1987, another tumor in 2017, and cancer found again in 2022, PET scans every 3-4 months were clear and she described herself as in remission again as of May 2025.

breastcancer.orgRead more →

Stage IV Colorectal Cancer: Rebecca's Patient Story

Patient Info: Rebecca Goins, Female, Under 40 | Stage IV

Metastatic Site: Not specified

Recurrent Stage IVB colorectal cancer was found on PET scan after a prior remission; the recurrent tumor was described as inoperable and treatment options were limited to chemotherapy and radiation.

Fight Colorectal CancerRead more →

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.orgRead more →

Faith And Humility: Stage I Breast Cancer treatment and follow-up story

Patient Info: Anonymized, Female | Stage I

Completed surgery, chemotherapy, and radiotherapy for early breast cancer about 9 months before the story and was living in recovery; no explicit NED/cancer-free status is stated.

breastcancer.orgRead more →

Stage III Breast Cancer: Cher's Survivor Story

Patient Info: Cher, Female | Stage III

Biomarkers: Hormone-positive; HER2-negative; Oncotype DX score 0

No evidence of disease after treatment for Stage IIIB breast cancer, with ongoing adjuvant Verzenio, long-term hormone blockers, and planned preventive mastectomy/DIEP flap reconstruction.

breastcancer.orgRead more →

Triple-Negative Breast Cancer: Valerie's Survivor Story

Patient Info: Valerie Hamilton, Female, 50s | Stage Metastatic/Advanced

Biomarkers: Triple-negative breast cancer; ER-negative; PR-negative; HER2-negative

Valerie completed chemotherapy, lumpectomy and radiation for locally advanced triple-negative breast cancer and preserved her breast/body image; no explicit NED or cancer-free status was provided.

Memorial Sloan KetteringRead more →

Stage I Invasive Ductal Carcinoma: Jill's Survivor Story

Patient Info: Jill, Female | Stage I

Biomarkers: Gene profile used to help avoid chemotherapy; specific biomarkers not reported

Jill completed lumpectomy, sentinel node biopsy and 4 weeks of hypofractionated radiation for Stage I invasive ductal carcinoma, avoided chemotherapy, and moved into recovery; no explicit NED/cancer-free status was provided.

Memorial Sloan KetteringRead more →

Colorectal Cancer: Danny's Survivor Story

Patient Info: Danny Soto, Male | Stage Metastatic/Advanced

Biomarkers: Lynch syndrome

Danny became cancer-free with no evidence of disease after extensive surgery and intraoperative radiation for complex colon cancer, and returned to work as a firefighter with follow-up visits every 6 months.

Memorial Sloan KetteringRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan KetteringRead more →

Stage IV Breast Cancer: Amy's Survivor Story

Patient Info: Amy Mannarino, Female, 50s | Stage IV

Metastatic Site: Brain

After brain metastasis surgery and 3 radiation sessions, Amy was doing well with no evidence of disease; the source specifically distinguishes NED from being cured or cancer-free in the setting of metastatic disease.

Memorial Sloan KetteringRead more →

Colorectal Cancer: Elizabeth's Survivor Story

Patient Info: Elizabeth, Female

After chemotherapy, radiation, sphincter-preserving surgery and temporary ostomy reversal, Elizabeth had no evidence of disease after 5 years of careful follow-up, with good GI function and quality of life.

Memorial Sloan KetteringRead more →

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan KetteringRead more →

Stage II Invasive Ductal Carcinoma: Dwan's Survivor Story

Patient Info: Dwan Thomas, Female | Stage II

Biomarkers: HER2-negative; estrogen-positive

Dwan completed treatment for Stage II HER2-negative, estrogen-positive invasive ductal carcinoma in 2017 and later became active in MD Anderson advocacy and fundraising efforts.

MD AndersonRead more →

Sexual safety during FOLFOX treatment for Stage III rectal cancer

Patient Info: Anonymized, female, 50s | Stage III

A 54-year-old woman with Stage III rectal cancer raised a practical sexual-health question while receiving FOLFOX, leading to direct measurement of oxaliplatin exposure in vaginal secretions.

PubMed CentralRead more →